Digital Brazil B2B: Infrastructure Dependency Risks
Brazilian companies are rapidly adopting digital tools to enhance their efficiency and global competitiveness, creating significant market opportunities. This basket offers exposure to US and EU-listed technology leaders that provide the essential software, cloud infrastructure, and cybersecurity services driving this change.
Your Basket's Financial Footprint
Market capitalisation breakdown and concise investor takeaways for the basket.
- Large-cap dominance generally implies lower volatility and more stable returns, closer to broad-market performance.
- Use as a core, long-term holding rather than a speculative allocation in a diversified portfolio.
- Expect steady, long-term appreciation likely, not rapid short-term, explosive gains.
MSFT: $3.95T
ORCL: $802.21B
SAP: $336.40B
- Other
About This Group of Stocks
Our Expert Thinking
Brazilian companies are undergoing a massive digital shift, investing heavily in cloud platforms, enterprise software, and cybersecurity to compete globally. This transformation creates sustained demand for the technology infrastructure that powers modern business operations, positioning global tech leaders as key beneficiaries of Brazil's economic modernisation.
What You Need to Know
This group focuses on established technology giants listed on US and EU exchanges that provide essential digital tools to Brazilian corporations. These companies offer the foundational platforms - from cloud hosting to customer management systems - that Brazilian businesses need to streamline operations and enhance productivity in today's digital economy.
Why These Stocks
These stocks were handpicked as the dominant global providers of cloud infrastructure, enterprise SaaS solutions, and cybersecurity services that Brazilian companies rely on for their digital transformation. Each company plays a crucial role in supplying the technology backbone that enables Brazilian businesses to modernise and compete internationally.
Why You'll Want to Watch These Stocks
Brazil's Digital Revolution
Brazilian companies are rapidly modernising their operations with cutting-edge technology. This massive shift creates sustained demand for the digital infrastructure and software solutions these global tech leaders provide.
Global Giants, Local Impact
These established technology companies are the backbone of Brazil's corporate transformation. As Brazilian businesses go digital, these firms benefit from increased demand for their cloud, software, and security services.
Long-Term Growth Driver
Brazil's B2B digital transformation isn't a short-term trend - it's a structural shift that will drive demand for enterprise technology for years to come. These companies are positioned at the centre of this opportunity.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Railroad Investment: Beyond the $85 Billion Merger
Union Pacific and Norfolk Southern are seeking to merge, creating America's first transcontinental railroad. This landmark consolidation could drive significant investment into rail infrastructure and technology, creating opportunities for companies that support and equip the freight rail industry.
Oracle TikTok Deal May Boost Stocks in 2025
TikTok has finalized the sale of its U.S. operations to an investor group including Oracle, resolving national security concerns and securing its future in the American market. This development creates opportunities for companies in the digital advertising, social commerce, and creator economy sectors that can now capitalize on the platform's stabilized presence and massive user base.
Pharma Reshoring Explained | Manufacturing Investment
Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.